Publications and Digital Products

This fact sheet for teens provides facts about heroin. It describes short- and long-term effects, lists signs of use, and helps dispel common myths. It also can be used by prevention professionals, educators, health care providers, and others who come in contact with teens on a regular basis.

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

This kit discusses the consequences of substance misuse among college students including the misuse of prescription and over-the-counter drugs. It explores various causational factors such as peer pressure, stress, social norms, and advertising messages.

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.

Summarizes key findings from the 2015 National Survey on Drug Use and Health (NSDUH) for indicators of substance use and mental health among people aged 12 years old or older in the civilian, non-institutionalized population of the United States.

This report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.

This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status.

This report provides 2013 estimates on the prevalence of substance use disorder and mental illness in the United States. It also reports on the need for and barriers to substance use treatment, mental health care, and co-occurring substance use disorders and mental illness.

This report discusses results from a survey on the use of illicit substances, alcohol, and tobacco among people ages 12 years or older. It focuses on trends between 2012 and 2013 and from 2002 to 2013, as well as differences among population groups.